Pathogen and antimicrobial resistance profiles of culture-proven neonatal sepsis in Southwest China, 1990-2014
Aim Neonatal sepsis (NS) sustains high mortality and morbidity in China, but data on the epidemiology and antimicrobial resistance patterns of NS pathogens are limited. Methods The clinical features, aetiology and antimicrobial resistance of culture‐proven NS were analysed over a period of 25 years...
Gespeichert in:
Veröffentlicht in: | Journal of paediatrics and child health 2016-10, Vol.52 (10), p.939-943 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 943 |
---|---|
container_issue | 10 |
container_start_page | 939 |
container_title | Journal of paediatrics and child health |
container_volume | 52 |
creator | Lu, Qi Zhou, Min Tu, Yan Yao, Yao Yu, Jialin Cheng, Shupeng |
description | Aim
Neonatal sepsis (NS) sustains high mortality and morbidity in China, but data on the epidemiology and antimicrobial resistance patterns of NS pathogens are limited.
Methods
The clinical features, aetiology and antimicrobial resistance of culture‐proven NS were analysed over a period of 25 years in the metropolitan city of Chongqing in Southwest China.
Results
The occurrence rates of neonatal early‐onset sepsis (EOS) were found to gradually decrease while late‐onset sepsis (LOS) was kept stable from 1990 to 2014. Although coagulase‐negative staphylococcus (CoNS) sepsis accounted for most infections, the occurrence rates of CoNS sepsis gradually decreased, especially in EOS. Escherichia coli and Klebsiella were common Gram‐negative bacteria. The occurrence rates of E. coli and Klebsiella remained stable in EOS; however, in LOS, those had increased mildly, especially from 2009 to 2014. Although a high‐degree resistance to common first‐ and second‐line antimicrobials was observed for the main causative pathogens of NS, the gentamicin‐resistance rate declined gradually from the year 2003. Similarly, the ceftazidime‐resistance rate of E. coli dropped gradually from the year 2007.
Conclusions
The alarmingly high degree of antibiotic resistance calls for urgent evaluation and development of antibiotic policy and protocols for the treatment of NS. Clinicians should strictly control the antibiotics use, decrease invasive manipulations and shorten hospitalisation to prevent LOS. |
doi_str_mv | 10.1111/jpc.13278 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835388619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4213825741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5278-24f786f478d83dfb707c7b44ccfa49fabdec32dc19bcb1001947874016ceafe63</originalsourceid><addsrcrecordid>eNp1kV1LHDEYhUOpVF174R-QgDctdHaTSWaSubRL_WJRQcvC3oRMJulmO5tZkxmt_963XfVCaCAkhOc9nJyD0CElYwprstqYMWW5kB_QHuWcZFQU_CPcCeMZl5Tsov2UVoSQvCjkJ7Sbi4IQUbE9FG50v-x-2YB1aGD3fu1N7GqvWxxt8qnXwVi8iZ3zrU24c9gMbT9Em8HbA8wF2wXdA57sBnjsA77thn75aFOPp0sf9DdMq4pkOaH8AO043Sb7-eUcoZ-nP-6m59ns-uxiejLLTAHfyHLuhCwdF7KRrHG1IMKImnNjnOaV03VjDcsbQ6va1JQQWgEqOKGlsdrZko3Ql60umLwfwIla-2Rs22qwOyRFJSuYlCWtAD1-h666IQZwB1QumWCiFEB93VIQTkrROrWJfq3jk6JE_S1BQQnqXwnAHr0oDvXaNm_ka-oATLbAI2T69H8ldXkzfZXMthNQiP3zNqHjbwXmRKHmV2dqcfqdzQXN1YI9A9CPn28</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1828373767</pqid></control><display><type>article</type><title>Pathogen and antimicrobial resistance profiles of culture-proven neonatal sepsis in Southwest China, 1990-2014</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Lu, Qi ; Zhou, Min ; Tu, Yan ; Yao, Yao ; Yu, Jialin ; Cheng, Shupeng</creator><creatorcontrib>Lu, Qi ; Zhou, Min ; Tu, Yan ; Yao, Yao ; Yu, Jialin ; Cheng, Shupeng</creatorcontrib><description>Aim
Neonatal sepsis (NS) sustains high mortality and morbidity in China, but data on the epidemiology and antimicrobial resistance patterns of NS pathogens are limited.
Methods
The clinical features, aetiology and antimicrobial resistance of culture‐proven NS were analysed over a period of 25 years in the metropolitan city of Chongqing in Southwest China.
Results
The occurrence rates of neonatal early‐onset sepsis (EOS) were found to gradually decrease while late‐onset sepsis (LOS) was kept stable from 1990 to 2014. Although coagulase‐negative staphylococcus (CoNS) sepsis accounted for most infections, the occurrence rates of CoNS sepsis gradually decreased, especially in EOS. Escherichia coli and Klebsiella were common Gram‐negative bacteria. The occurrence rates of E. coli and Klebsiella remained stable in EOS; however, in LOS, those had increased mildly, especially from 2009 to 2014. Although a high‐degree resistance to common first‐ and second‐line antimicrobials was observed for the main causative pathogens of NS, the gentamicin‐resistance rate declined gradually from the year 2003. Similarly, the ceftazidime‐resistance rate of E. coli dropped gradually from the year 2007.
Conclusions
The alarmingly high degree of antibiotic resistance calls for urgent evaluation and development of antibiotic policy and protocols for the treatment of NS. Clinicians should strictly control the antibiotics use, decrease invasive manipulations and shorten hospitalisation to prevent LOS.</description><identifier>ISSN: 1034-4810</identifier><identifier>EISSN: 1440-1754</identifier><identifier>DOI: 10.1111/jpc.13278</identifier><identifier>PMID: 27500793</identifier><language>eng</language><publisher>Australia: John Wiley & Sons Australia, Ltd</publisher><subject>Anti-Bacterial Agents - therapeutic use ; antibiotic resistance ; Antibiotics ; Antimicrobial agents ; Bacteremia - drug therapy ; Bacteremia - epidemiology ; Blood-Borne Pathogens - drug effects ; causative pathogen ; China - epidemiology ; Culture Techniques ; Databases, Factual ; Drug resistance ; Drug Resistance, Microbial - drug effects ; E coli ; early-onset sepsis ; Female ; Humans ; Infant, Newborn ; Intensive Care Units, Neonatal ; late-onset sepsis ; Length of Stay ; Male ; neonatal sepsis ; Neonatal Sepsis - drug therapy ; Neonatal Sepsis - mortality ; Retrospective Studies ; Sepsis</subject><ispartof>Journal of paediatrics and child health, 2016-10, Vol.52 (10), p.939-943</ispartof><rights>2016 Paediatrics and Child Health Division (The Royal Australasian College of Physicians)</rights><rights>2016 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).</rights><rights>2016 Paediatrics and Child Health Division (Royal Australasian College of Physicians)</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5278-24f786f478d83dfb707c7b44ccfa49fabdec32dc19bcb1001947874016ceafe63</citedby><cites>FETCH-LOGICAL-c5278-24f786f478d83dfb707c7b44ccfa49fabdec32dc19bcb1001947874016ceafe63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjpc.13278$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjpc.13278$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27500793$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Qi</creatorcontrib><creatorcontrib>Zhou, Min</creatorcontrib><creatorcontrib>Tu, Yan</creatorcontrib><creatorcontrib>Yao, Yao</creatorcontrib><creatorcontrib>Yu, Jialin</creatorcontrib><creatorcontrib>Cheng, Shupeng</creatorcontrib><title>Pathogen and antimicrobial resistance profiles of culture-proven neonatal sepsis in Southwest China, 1990-2014</title><title>Journal of paediatrics and child health</title><addtitle>Journal of Paediatrics and Child Health</addtitle><description>Aim
Neonatal sepsis (NS) sustains high mortality and morbidity in China, but data on the epidemiology and antimicrobial resistance patterns of NS pathogens are limited.
Methods
The clinical features, aetiology and antimicrobial resistance of culture‐proven NS were analysed over a period of 25 years in the metropolitan city of Chongqing in Southwest China.
Results
The occurrence rates of neonatal early‐onset sepsis (EOS) were found to gradually decrease while late‐onset sepsis (LOS) was kept stable from 1990 to 2014. Although coagulase‐negative staphylococcus (CoNS) sepsis accounted for most infections, the occurrence rates of CoNS sepsis gradually decreased, especially in EOS. Escherichia coli and Klebsiella were common Gram‐negative bacteria. The occurrence rates of E. coli and Klebsiella remained stable in EOS; however, in LOS, those had increased mildly, especially from 2009 to 2014. Although a high‐degree resistance to common first‐ and second‐line antimicrobials was observed for the main causative pathogens of NS, the gentamicin‐resistance rate declined gradually from the year 2003. Similarly, the ceftazidime‐resistance rate of E. coli dropped gradually from the year 2007.
Conclusions
The alarmingly high degree of antibiotic resistance calls for urgent evaluation and development of antibiotic policy and protocols for the treatment of NS. Clinicians should strictly control the antibiotics use, decrease invasive manipulations and shorten hospitalisation to prevent LOS.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacteremia - drug therapy</subject><subject>Bacteremia - epidemiology</subject><subject>Blood-Borne Pathogens - drug effects</subject><subject>causative pathogen</subject><subject>China - epidemiology</subject><subject>Culture Techniques</subject><subject>Databases, Factual</subject><subject>Drug resistance</subject><subject>Drug Resistance, Microbial - drug effects</subject><subject>E coli</subject><subject>early-onset sepsis</subject><subject>Female</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Intensive Care Units, Neonatal</subject><subject>late-onset sepsis</subject><subject>Length of Stay</subject><subject>Male</subject><subject>neonatal sepsis</subject><subject>Neonatal Sepsis - drug therapy</subject><subject>Neonatal Sepsis - mortality</subject><subject>Retrospective Studies</subject><subject>Sepsis</subject><issn>1034-4810</issn><issn>1440-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kV1LHDEYhUOpVF174R-QgDctdHaTSWaSubRL_WJRQcvC3oRMJulmO5tZkxmt_963XfVCaCAkhOc9nJyD0CElYwprstqYMWW5kB_QHuWcZFQU_CPcCeMZl5Tsov2UVoSQvCjkJ7Sbi4IQUbE9FG50v-x-2YB1aGD3fu1N7GqvWxxt8qnXwVi8iZ3zrU24c9gMbT9Em8HbA8wF2wXdA57sBnjsA77thn75aFOPp0sf9DdMq4pkOaH8AO043Sb7-eUcoZ-nP-6m59ns-uxiejLLTAHfyHLuhCwdF7KRrHG1IMKImnNjnOaV03VjDcsbQ6va1JQQWgEqOKGlsdrZko3Ql60umLwfwIla-2Rs22qwOyRFJSuYlCWtAD1-h666IQZwB1QumWCiFEB93VIQTkrROrWJfq3jk6JE_S1BQQnqXwnAHr0oDvXaNm_ka-oATLbAI2T69H8ldXkzfZXMthNQiP3zNqHjbwXmRKHmV2dqcfqdzQXN1YI9A9CPn28</recordid><startdate>201610</startdate><enddate>201610</enddate><creator>Lu, Qi</creator><creator>Zhou, Min</creator><creator>Tu, Yan</creator><creator>Yao, Yao</creator><creator>Yu, Jialin</creator><creator>Cheng, Shupeng</creator><general>John Wiley & Sons Australia, Ltd</general><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201610</creationdate><title>Pathogen and antimicrobial resistance profiles of culture-proven neonatal sepsis in Southwest China, 1990-2014</title><author>Lu, Qi ; Zhou, Min ; Tu, Yan ; Yao, Yao ; Yu, Jialin ; Cheng, Shupeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5278-24f786f478d83dfb707c7b44ccfa49fabdec32dc19bcb1001947874016ceafe63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacteremia - drug therapy</topic><topic>Bacteremia - epidemiology</topic><topic>Blood-Borne Pathogens - drug effects</topic><topic>causative pathogen</topic><topic>China - epidemiology</topic><topic>Culture Techniques</topic><topic>Databases, Factual</topic><topic>Drug resistance</topic><topic>Drug Resistance, Microbial - drug effects</topic><topic>E coli</topic><topic>early-onset sepsis</topic><topic>Female</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Intensive Care Units, Neonatal</topic><topic>late-onset sepsis</topic><topic>Length of Stay</topic><topic>Male</topic><topic>neonatal sepsis</topic><topic>Neonatal Sepsis - drug therapy</topic><topic>Neonatal Sepsis - mortality</topic><topic>Retrospective Studies</topic><topic>Sepsis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Qi</creatorcontrib><creatorcontrib>Zhou, Min</creatorcontrib><creatorcontrib>Tu, Yan</creatorcontrib><creatorcontrib>Yao, Yao</creatorcontrib><creatorcontrib>Yu, Jialin</creatorcontrib><creatorcontrib>Cheng, Shupeng</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of paediatrics and child health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Qi</au><au>Zhou, Min</au><au>Tu, Yan</au><au>Yao, Yao</au><au>Yu, Jialin</au><au>Cheng, Shupeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pathogen and antimicrobial resistance profiles of culture-proven neonatal sepsis in Southwest China, 1990-2014</atitle><jtitle>Journal of paediatrics and child health</jtitle><addtitle>Journal of Paediatrics and Child Health</addtitle><date>2016-10</date><risdate>2016</risdate><volume>52</volume><issue>10</issue><spage>939</spage><epage>943</epage><pages>939-943</pages><issn>1034-4810</issn><eissn>1440-1754</eissn><abstract>Aim
Neonatal sepsis (NS) sustains high mortality and morbidity in China, but data on the epidemiology and antimicrobial resistance patterns of NS pathogens are limited.
Methods
The clinical features, aetiology and antimicrobial resistance of culture‐proven NS were analysed over a period of 25 years in the metropolitan city of Chongqing in Southwest China.
Results
The occurrence rates of neonatal early‐onset sepsis (EOS) were found to gradually decrease while late‐onset sepsis (LOS) was kept stable from 1990 to 2014. Although coagulase‐negative staphylococcus (CoNS) sepsis accounted for most infections, the occurrence rates of CoNS sepsis gradually decreased, especially in EOS. Escherichia coli and Klebsiella were common Gram‐negative bacteria. The occurrence rates of E. coli and Klebsiella remained stable in EOS; however, in LOS, those had increased mildly, especially from 2009 to 2014. Although a high‐degree resistance to common first‐ and second‐line antimicrobials was observed for the main causative pathogens of NS, the gentamicin‐resistance rate declined gradually from the year 2003. Similarly, the ceftazidime‐resistance rate of E. coli dropped gradually from the year 2007.
Conclusions
The alarmingly high degree of antibiotic resistance calls for urgent evaluation and development of antibiotic policy and protocols for the treatment of NS. Clinicians should strictly control the antibiotics use, decrease invasive manipulations and shorten hospitalisation to prevent LOS.</abstract><cop>Australia</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>27500793</pmid><doi>10.1111/jpc.13278</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1034-4810 |
ispartof | Journal of paediatrics and child health, 2016-10, Vol.52 (10), p.939-943 |
issn | 1034-4810 1440-1754 |
language | eng |
recordid | cdi_proquest_miscellaneous_1835388619 |
source | MEDLINE; Wiley Journals |
subjects | Anti-Bacterial Agents - therapeutic use antibiotic resistance Antibiotics Antimicrobial agents Bacteremia - drug therapy Bacteremia - epidemiology Blood-Borne Pathogens - drug effects causative pathogen China - epidemiology Culture Techniques Databases, Factual Drug resistance Drug Resistance, Microbial - drug effects E coli early-onset sepsis Female Humans Infant, Newborn Intensive Care Units, Neonatal late-onset sepsis Length of Stay Male neonatal sepsis Neonatal Sepsis - drug therapy Neonatal Sepsis - mortality Retrospective Studies Sepsis |
title | Pathogen and antimicrobial resistance profiles of culture-proven neonatal sepsis in Southwest China, 1990-2014 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A33%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pathogen%20and%20antimicrobial%20resistance%20profiles%20of%20culture-proven%20neonatal%20sepsis%20in%20Southwest%20China,%201990-2014&rft.jtitle=Journal%20of%20paediatrics%20and%20child%20health&rft.au=Lu,%20Qi&rft.date=2016-10&rft.volume=52&rft.issue=10&rft.spage=939&rft.epage=943&rft.pages=939-943&rft.issn=1034-4810&rft.eissn=1440-1754&rft_id=info:doi/10.1111/jpc.13278&rft_dat=%3Cproquest_cross%3E4213825741%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1828373767&rft_id=info:pmid/27500793&rfr_iscdi=true |